Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro
- 1 April 1985
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 14 (3), 194-201
- https://doi.org/10.1007/bf00258115
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Phase II study of 9-hydroxy-2N-methylellipticinium acetateEuropean Journal of Cancer and Clinical Oncology, 1984
- Clinical evaluation of 4′-epi-doxorubicin in advanced solid tumorsInvestigational New Drugs, 1983
- Phase I trial of aclacinomycin-AInvestigational New Drugs, 1983
- CYTO-TOXIC EFFECTS AND BIOLOGICAL-ACTIVITY OF 2-AZA-8-GERMANSPIRO[4,5]-DECANE-2-PROPANAMINE-8,8-DIETHYL-N,N-DIMETHYLDICHLORIDE (NSC 192965 - SPIROGERMANIUM) INVITRO1982
- Activity of mitoxantrone in a human tumor cloning system.1981
- CELL KILL KINETICS OF SEVERAL NOGALAMYCIN ANALOGS AND ADRIAMYCIN FOR CHINESE-HAMSTER OVARY, L1210-LEUKEMIA, AND B-16-MELANOMA CELLS IN CULTURE1981
- Lethal and kinetic effects of DDMP (2,4-diamino-5-(3′,4′-dichlorophenyl)-6-methylpyrimidine)European Journal of Cancer (1965), 1979
- Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agents.1979
- Synthesis and antitumor activity of 4'-O-methyldaunorubicin, 4'-O-methyladriamycin, and their 4'-epi analogsJournal of Medicinal Chemistry, 1979
- STUDIES IN HISTOCHEMISTRY: I. DETERMINATION OF NUCLEIC ACIDS IN MICROGRAM AMOUNTS OF TISSUEJournal of Histochemistry & Cytochemistry, 1956